NKGen Biotech, Inc. (“NKGen”), a clinical-stage Natural Killer (NK) cell therapy company, has entered into a merger agreement with Graf Acquisition Corp. IV completed NKGen
In February 2026, a federal judge in Manhattan ruled that 31 documents a defendant generated with a consumer AI chatbot were not protected by attorney-client
A new analysis from The Schiller Kessler Group of national mortality data has found that preventable injury claimed 197,449 American lives in 2024, an average
Traffic surrounding a major stadium event can begin hours before the first spectator enters the venue and continue well after the crowd has gone home.